ClearPoint Neuro, Inc. (CLPT)
11.12
-0.52
(-4.47%)
USD |
NASDAQ |
May 18, 16:00
11.15
+0.03
(+0.27%)
After-Hours: 20:00
ClearPoint Neuro EPS Diluted (Quarterly) : -0.3233 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.06 |
| Stryker Corp. | 1.928 |
| UFP Technologies, Inc. | 2.243 |
| Tandem Diabetes Care, Inc. | -0.2982 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.552M |
| Revenue (Quarterly) | 12.13M |
| Total Expenses (Quarterly) | 21.68M |
| Enterprise Value | 377.07M |
| Gross Profit Margin (Quarterly) | 62.24% |
| Profit Margin (Quarterly) | -78.76% |
| Earnings Yield | -9.07% |
| Normalized Earnings Yield | -9.066 |